Zanaflex
M&A
STATUS
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Zanaflex is an essential compound useful in treating serious illnesses. It will be used to produce capsules or tablets for the treatment of spinal cord injuries or multiple sclerosis as well as brain injuries and strokes.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Zanaflex Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Zanaflex‘s full profile, request access.
Request full access to PitchBook